Using drug probes to monitor hepatic drug metabolism in critically ill patients: midazolam, a flawed but useful tool for clinical investigation of CYP3A activity?
about
Sensitivity of intravenous and oral alfentanil and pupillary miosis as minimal and noninvasive probes for hepatic and first-pass CYP3A induction.Concurrent assessment of hepatic and intestinal cytochrome P450 3A activities using deuterated alfentanilXenobiotic metabolism: the effect of acute kidney injury on non-renal drug clearance and hepatic drug metabolismDevelopmental changes in the expression and function of cytochrome P450 3A isoforms: evidence from in vitro and in vivo investigations.The effects of acute renal failure on drug metabolism.Simultaneous determination of alfentanil and midazolam in human plasma using liquid chromatography and tandem mass spectrometry
P2860
Using drug probes to monitor hepatic drug metabolism in critically ill patients: midazolam, a flawed but useful tool for clinical investigation of CYP3A activity?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Using drug probes to monitor h ...... vestigation of CYP3A activity?
@en
Using drug probes to monitor h ...... vestigation of CYP3A activity?
@nl
type
label
Using drug probes to monitor h ...... vestigation of CYP3A activity?
@en
Using drug probes to monitor h ...... vestigation of CYP3A activity?
@nl
prefLabel
Using drug probes to monitor h ...... vestigation of CYP3A activity?
@en
Using drug probes to monitor h ...... vestigation of CYP3A activity?
@nl
P2093
P2860
P50
P1476
Using drug probes to monitor h ...... vestigation of CYP3A activity?
@en
P2093
Barbara Philips
Chris Kirwan
Iain MacPhee
P2860
P304
P356
10.1517/17425255.2010.482929
P407
P577
2010-06-01T00:00:00Z